Today, Inspire Medical Systems, Inc. announced certain preliminary, unaudited results for the fourth quarter and full year that ended December 31, 2023, and provided its initial full-year 2024 guidance. Preliminary, Unaudited Fourth Quarter and Full Year 2023 Revenue and Recent Business Highlights Revenue for the fourth quarter of 2023 is […]
Industry News
Acquisitions | Awards | Events | News | Partnerships
Sunrise Secures $6M Investment from Amazon’s Alexa Fund & UI-Investissement
Sunrise has received an additional aggregate investment of $6 million from the Alexa Fund and French healthcare investor UI-Investissement (Majycc Innovation Santé), for a total of $24 million raised this year. This news comes after a breakthrough year for Sunrise. With two FDA approvals in the United States, the renewed […]
sovaSage Inc. Announces Integration with React Health Connect Platform
sovaSage Inc., a privately held company selling artificial intelligence-based software and services for the management of obstructive sleep apnea, today announced that it has completed data integration with React Health’s Connect patient management software platform. Earlier this year, sovaSage introduced the first AI-based continuous positive airway pressure (CPAP) coach technology, Jeanie. The Jeanie™ Compliance Management Service is […]
EnsoData and React Health Partner to Improve Outcomes with Predictive AI
EnsoData, a leading provider of artificial intelligence (AI) solutions to assist with sleep testing, diagnosis, and treatment, and React Health, a sleep and respiratory device manufacturer based in Sarasota, FL, have announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea. EnsoData’s revolutionary adherence prediction AI […]
Q&A: The Future of Sleep Technology in an Evolving World with Laura Linley
On a recent EnsoData webinar, Today is NOT tomorrow in Sleep Technology, sleep technologists and physicians asked questions on the future of sleep medicine, the growing impact of AI on sleep, and how labs are handling modern challenges, like authorization issues and staffing shortages. The webinar host, Laura Linley, CRT, […]
ResMed Acquires Somnoware
ResMed today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment […]
Somnoware Integrates React Health PAP Device Data into Care Management Platform
Somnoware Healthcare Systems Inc announced that the company is partnering with React Health to integrate data from React’s connected PAP devices into Somnoware’s new Care Management platform. The integration will enable PAP therapy data to be displayed in Somnoware’s Care Management through connecting to iCodeConnect, React’s cloud-based platform for clinicians to gather patient […]
Nox Health Closes Acquisition of Somryst
Nox Health announced that it has closed the acquisition of Somryst, the first and only FDA-approved prescription digital therapeutic that delivers effective, first-line treatment for adults with chronic insomnia. The addition of Somryst expands Nox Health’s comprehensive suite of tools and programs that address a critical and growing demand for sleep […]
SomnoMed Partners with Nexus Dental Systems to Improve Access to Oral Appliance Therapy for OSA Patients
SomnoMed North America announces Nexus Dental Systems (Nexus) as their preferred partner to offer sleep dentistry training and medical billing in the DOD, VA and commercial market segments. “This partnership significantly enhances the objectives of SomnoMed’s Medical Initiative by further enabling and expanding collaborative patient treatment pathways between medical prescribers, […]
FDA Approves lnspire for AHI Indication Expansion and Increased BMI Labeling
Inspire Medical Systems, Inc. announced that it has received approval from the Food and Drug Administration (FDA) on an expanded indication. The update includes an increase on the upper limit of the Apnea-Hypopnea Index (AHI) to 100 events per hour from 65 and raises the Body Mass Index (BMI) warning […]












